Key facts
- Notable investors include Zhuhai High-tech Financial Investment, Zhuhai Gree Financial Investment, Fushilai.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Refurm Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Refurm Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Refurm Biotechnology
Manufacturer of medical beauty products designed to repair and beautify skin tissue. The company engages in the research and development of extracellular matrix that can induce and regenerate the activity of human cells, enabling clients to achieve in situ repair of skin tissues and scientific medical cosmetic purposes.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shenzhen, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Refurm Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Refurm Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Refurm Biotechnology in its N-PORT filings yet. We sweep new filings monthly.